Marshall S. Stanton - Concepedia

Author

Marshall S. Stanton

Also Known As

M S Stanton, M Stanton, M. S. Stanton, M. Stanton, M.S. Stanton, MARSHALL S. STANTON, Marshall S Stanton, Marshall S. Stanton, Marshall Stanton

136

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Medtronic (United States)Mayo Clinic in Arizona Indiana University – Purdue University Indianapolis Richard L. Roudebush VA Medical Center

About

Marshall S. Stanton is an author at Mayo Clinic specializing in medicine, cardiology, and electrophysiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	1K
2	Public Health	4	4	668
3	Social Sciences	2	2	111
4	Engineering	1	1	55
5	Anesthesia	1	1	24

Marshall S. Stanton

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy Barry J. Maron, Win-Kuang Shen, Mark S. Link, New England Journal of Medicine	2000	1K
Allelic Variants in Long-QT Disease Genes in Patients With Drug-Associated Torsades de Pointes Ping Yang, Hideaki Kanki, Benoît Drolet, Circulation	2002	551
Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine Marshall S. Stanton, Mahmoud Tuli, Nancy L. Radtke, Journal of the American College of Cardiology Cardiac MuscleHeart FailureCardiogenic ShockCardiovascular DiseaseMedicine	1989	261
Clinical features of amiodarone-induced pulmonary toxicity. Raymond E. Dusman, Marshall S. Stanton, William M. Miles, Circulation Acute Lung InjuryAsthmaHeart FailurePulmonary CareLung Inflammation	1990	239
Atrial Therapies Reduce Atrial Arrhythmia Burden in Defibrillator Patients Paul A. Friedman, Barbara Dijkman, Eduardo N. Warman, Circulation	2001	161
Arrhythmogenic effects of antiarrhythmic drugs: A study of 506 patients treated for ventricular tachycardia or fibrillation Marshall S. Stanton, Eric N. Prystowsky, Naomi S. Fineberg, Journal of the American College of Cardiology Arrhythmogenic EffectsCardiovascular DiseaseMyocardial InfarctionPharmacologyCardiovascular Pharmacology	1989	136
Global Right Atrial Mapping of Human Atrial Flutter: The Presence of Posteromedial (Sinus Venosa Region) Functional Block and Double Potentials Paul A. Friedman, David Luria, Alexis M. Fenton, Circulation	2000	119
Five-year follow-up of 589 patients treated with amiodarone Bradley A. Weinberg, William M. Miles, Lawrence S. Klein, American Heart Journal Five-year Follow-upClinical TrialsPharmacotherapyMedicineAdverse Drug Reaction	1993	117
Adenosine: Potential modulator for vasovagal syncope Win-Kuang Shen, Stephen C. Hammill, Thomas M. Munger, Journal of the American College of Cardiology Signal TransductionNeurophysiologyMedicineVascular PharmacologyPhysiology	1996	87
Is Sinus Node Modification Appropriate for Inappropriate Sinus Tachycardia with Features of Postural Orthostatic Tachycardia Syndrome? WIN‐KUANG SHEN, Phillip A. Low, Arshad Jahangir, Pacing and Clinical Electrophysiology	2001	69

Page 1